Verichem Launches Biosynthetic Clinical Reference Materials for Urine Chemistry Assays
Verichem Labs’ biosynthetic clinical reference materials are for the calibration verification and quality control of urine chemistry assays.
Read MorePosted by Andy Lundin | Jan 17, 2025 | Controls |
Verichem Labs’ biosynthetic clinical reference materials are for the calibration verification and quality control of urine chemistry assays.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Compliance |
Xifin’s CEO sees a window of opportunity for lawmakers to modify the Final Rule on LDTs that will be a win-win for the industry and patients.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Cancer, Digital Pathology |
Leica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Accreditation |
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read MorePosted by Chris Wolski | Dec 20, 2024 | Analytical Software Systems |
Indica Labs has been selected by the University of Bern to deploy its HALO AP digital pathology platform in the cloud.
Read More